AgingResearch.NewsJoin free

Bone health quality improvement program

Intervention

1 paper2 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • Human trial1

Outcomes

2

Osteoporosis treatment initiation rate

upin humans1

1 study

  1. Bone health quality improvement program increases osteoporosis treatment initiation rate in humans (+3.6% (from 74.5% to 78.1%)).

    “Treatment initiation rates improved from 74.5% to 78.1% in the resident panel (a 3.6% increase), while rates for the attending and overall panels remained relatively stable.”

    Human trialresident paneln = 76

    SAT-798 Stronger Bones For A Stronger Life: Implementing Bone Health

    ENDO 2025 abstract22 Oct 2025

Osteoporosis screening rate

upin humans1

1 study

  1. Bone health quality improvement program increases osteoporosis screening rate in humans (from 43.4% to 45.9%).

    “The resident panel achieved the targeted 2.5% increase in screening.”

    Human trialresident paneln = 314

    SAT-798 Stronger Bones For A Stronger Life: Implementing Bone Health

    ENDO 2025 abstract22 Oct 2025

Latest

Related